SyrSpend SF, Ciprofloxacin Kabi 200 mg/100 ml solution for infusion clinical trials

A single blind, placebo controlled, single center, randomized controlled pilot study to assess if low dose ciprofloxacin can induce antimicrobial resistance in Escherichia coli

This study looks at whether a small amount of a common antibiotic, ciprofloxacin, can make bacteria in your gut, E. coli, resistant to antibiotics. It compares a real drug to a dummy drug to understand how this happens.